Association between urate-lowering treatments and cognitive decline in community-dwelling older adults

  • Franceschi, C., Garagnani, P., Parini, P., Giuliani, C. & Santoro, A. Inflammaging: A new immuno-metabolic perspective for age-related diseases. Nat. Rev. Endocrinol. 14576-590 (2018).

    CAS Google Scholar Article

  • Butterfield, DA & Halliwell, B. Oxidative stress, dysfunctional glucose metabolism, and Alzheimer’s disease. Nat. Rev. Neurosci. 20148-160 (2019).

    CAS Google Scholar Article

  • Tuven, B., Soysal, P., Unutmaz, G., Kaya, D. & Isik, AT Uric acid may protect against cognitive impairment in older adults, but only in those without risk factors cardiovascular. Exp. Gerontol. 8915-19 (2017).

    CAS Google Scholar Article

  • Mon. et al. Gout and the risk of Alzheimer’s disease: a population-based, BMI-matched cohort study. Ann. Common cold. Say. 75547–551 (2016).

    CAS Google Scholar Article

  • Latourte, A., Bardin, T. & Richette, P. Uric acid and cognitive decline: a double-edged sword?. Running. Notice. Rheumatol. 30183–187 (2018).

    CAS Google Scholar Article

  • Singh, JA & Cleveland, JD Gout and dementia in the elderly: a cohort study of health insurance claims. BMC Geriatrics 18(2018).

  • Moorhouse, PC, Grootveld, M., Halliwell, B., Quinlan, JG & Gutteridge, JM Allopurinol and oxypurinol are hydroxyl radical scavengers. FEBS Letter 21323–28 (1987).

    CAS Google Scholar Article

  • Fukui, T. et al. Effects of febuxostat on oxidative stress. Clin. The. 371396-1401 (2015).

    CAS Google Scholar Article

  • Zhang, Q. et al. Allopurinol protects against ischemic insults in a mouse model of cortical microinfarction. Brain Res. 1622361–367 (2015).

    CAS Google Scholar Article

  • Maiwald, California et al. Effect of allopurinol in addition to treatment of hypothermia in neonates with hypoxic-ischemic brain injury on neurocognitive outcomes (ALBINO): study protocol of a multicenter, parallel-group, randomized, controlled trial in blinded for superiority (Phase III). BMC Pediatr. 19210 (2019).

    Google Scholar article

  • Singh, JA and Cleveland, JD Comparative efficacy of allopurinol versus febuxostat for preventing incident dementia in the elderly: a matched propensity analysis. Arthritis Res. The. 20167 (2018).

    Google Scholar article

  • Latourte, A. et al. Uric acid and incident dementia at 12 years of follow-up: a population-based cohort study. Ann. Common cold. Say. 77328–335 (2018).

    CAS Google Scholar Article

  • Scheepers, LEJM et al. Urate and risk of Alzheimer’s disease and vascular dementia: a population-based study. Alzheimer’s dementia 15754–763 (2019).

    Google Scholar article

  • Engel, B. et al. Hyperuricemia and dementia – a case-control study. BMC Neurol 18(2018).

  • Erkinjuntti, T., Ostbye, T., Steenhuis, R. & Hachinski, V. The effect of different diagnostic criteria on the prevalence of dementia. N.Engl. J.Med. 3371667–1674 (1997).

    CAS Google Scholar Article

  • Vellas, B. et al. Mapt study: A multidomain approach to prevent Alzheimer’s disease: Design and basic data. J. Prev. Alzheimer’s disease 113–22 (2014).

    CAS Google Scholar

  • Andrieu, S. et al. Effect of long-term omega-3 polyunsaturated fatty acid supplementation with or without multidomain intervention on cognitive function in older adults with memory impairment (MAPT): a randomized placebo-controlled trial. Neurol Lancet 16377–389 (2017).

    CAS Google Scholar Article

  • Richet, P. et al. 2016 update of EULAR evidence-based recommendations for the management of gout. Ann. Common cold. Say. 7629–42 (2017).

    CAS Google Scholar Article

  • Pacher, P., Nivorozhkin, A. & Szabó, C. Therapeutic effects of xanthine oxidase inhibitors: Rebirth half a century after the discovery of allopurinol. Pharmacol Rev. 5887–114 (2006).

    CAS Google Scholar Article

  • Slobodnick, A., Shah, B., Krasnokutsky, S. & Pillinger, MH Colchicine Update, 2017. Rheumatology (Oxford) 57i4–i11 (2018).

    CAS Google Scholar Article

  • Kippen, I., Whitehouse, MW & Klinenberg, JR Pharmacology of uricosuric drugs. Ann. Rheum Dis. 33391–396 (1974).

    CAS Google Scholar Article

  • Rafin, J. et al. Associations between physical activity, blood biomarkers of neurodegeneration, and cognition in healthy older adults: the MAPT study. J. Gerontol A Biol. Science. Med. Science. 761382–1390 (2021).

    CAS Google Scholar Article

  • Johnson, RJ et al. Uric acid and chronic kidney disease: who is chasing whom?. Nephrol Dial Graft 282221-2228 (2013).

    CAS Google Scholar Article

  • Richet, P. et al. Improving cardiovascular and renal outcomes in gout: what should we be targeting?. Nat. Rev. Rheumatol ten654–661 (2014).

    CAS Google Scholar Article

  • Sluijs, I. et al. A Mendelian randomization study of circulating uric acid and type 2 diabetes. Diabetes 643028-3036 (2015).

    CAS Google Scholar Article

  • Massi, S. et al. The complex relationship between serum uric acid, endothelial function and small vessel remodeling in man. J. Clin. Med. 9E2027 (2020).

    Google Scholar article

  • Khosla, UM et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 671739–1742 (2005).

    Google Scholar article

  • Goicoechea, M. et al. Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin. Jam. Soc. Nephrol 51388–1393 (2010).

    CAS Google Scholar Article

  • Khan, AA, Quinn, TJ, Hewitt, J., Fan, Y. & Dawson, J. Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis. Age (Dordr.) 3816 (2016).

    Google Scholar article

  • Wishart, DS et al. DrugBank 5.0: A major update to the DrugBank database for 2018. Nucleic Acids Res. 46D1074–D1082 (2018).

    CAS Google Scholar Article

  • Lagorce, D., Douguet, D., Miteva, MA & Villoutreix, BO Computational analysis of physicochemical and calculated ADMET properties of protein-protein interaction inhibitors. Science. representing seven(2017).

  • Scherrmann, JM Drug delivery to the brain via the blood-brain barrier. Vascul. Pharmacol. 38349-354 (2002).

    CAS Google Scholar Article

  • Muir, SW et al. Allopurinol use produces potentially beneficial effects on inflammatory indices in people with recent ischemic stroke: a randomized, double-blind, placebo-controlled trial. Stroke 393303–3307 (2008).

    CAS Google Scholar Article

  • Sonnen, JA et al. Pathological correlates of dementia in a population-based longitudinal aging sample. Ann. Neurol 62406–413 (2007).

    Google Scholar article

  • Haglund, M., Passant, U., Sjöbeck, M., Ghebremedhin, E. & Englund, E. Cerebral amyloid angiopathy and cortical microinfarcts as putative substrates of vascular dementia. Int. J. Geriatr. Psychiatry 21681–687 (2006).

    Google Scholar article

  • Gifford, KA et al. The source of cognitive impairment predicts diagnostic conversion differently in older people without dementia. Alzheimer’s dementia ten319-327 (2014).

    Google Scholar article

  • Donohue, MC et al. The preclinical Alzheimer’s cognitive composite: measuring amyloid-related decline. JAMA Neurol 71961–970 (2014).

    Google Scholar article

  • Stamp, LK et al. Use of allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Rheumatic arthritis 63412-421 (2011).

    CAS Google Scholar Article

  • Jutkowitz, E., Choi, HK, Pizzi, LT & Kuntz, KM Cost effectiveness of allopurinol and febuxostat for the management of gout. Ann. Internal. Med. 161617-626 (2014).

    Google Scholar article

  • Jeyaruban, A., Larkins, S., and Soden, M. Management of gout in general practice – a systematic review. Clin. Rheumatol 349–16 (2015).

    Google Scholar article